Nanoparticle‐Based Drug Delivery System—A Target Strategy for Osteoarthritis Treatment

K Liu, D Zhang, W Wang - Journal of Nanomaterials, 2021 - Wiley Online Library
Osteoarthritis (OA) is a bone and joint disease with pathological characteristics such as
articular cartilage degeneration injury and synovial and subchondral bone reactive …

[HTML][HTML] Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management

J Wen, H Li, H Dai, S Hua, X Long, H Li, S Ivanovski… - Materials Today Bio, 2023 - Elsevier
Osteoarthritis (OA) and rheumatoid arthritis (RA) are chronic and progressive inflammatory
joint diseases that affect a large population worldwide. Intra-articular administration of …

[HTML][HTML] Development of nanomaterials to target articular cartilage for osteoarthritis therapy

C Rao, S Shi - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
Osteoarthritis (OA) is an obstinate, degradative, and complicated disease that has drawn
much attention worldwide. Characterized by its stubborn symptoms and various sequela, OA …

Nanomaterials for the local and targeted delivery of osteoarthritis drugs

P Chinnagounder Periyasamy… - Journal of …, 2012 - Wiley Online Library
Nanotechnology has found its potential in every possible field of science and engineering. It
offers a plethora of options to design tools at the nanometer scale, which can be expected to …

Nanotechnology application in drug delivery to osteoarthritis (OA), rheumatoid arthritis (RA), and osteoporosis (OSP)

M Rabiei, S Kashanian, SS Samavati… - Journal of drug delivery …, 2021 - Elsevier
Nanoparticles (NPs) show great promise as tools for designing formulations capable of
meeting the challenge of targeted and non-targeted drug delivery to bone and cartilage …

[HTML][HTML] An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application

S Amirsaadat, H Amirazad, R Hashemihesar… - … in Bioengineering and …, 2023 - frontiersin.org
Osteoarthritis (OA) is the most common progressive condition affecting joints. It mainly
affects the knees and hips as predominant weight-bearing joints. Knee osteoarthritis (KOA) …

Targeted treatment for osteoarthritis: drugs and delivery system

L Mao, W Wu, M Wang, J Guo, H Li, S Zhang, J Xu… - Drug …, 2021 - Taylor & Francis
The management of osteoarthritis (OA) is a clinical challenge due to the particular avascular,
dense, and occluded tissue structure. Despite numerous clinical reports and animal studies …

[HTML][HTML] Therapeutic potential of nanotechnology-based approaches in osteoarthritis

L Xiao, J Cui, Z Sun, Y Liu, J Zheng… - Frontiers in …, 2022 - frontiersin.org
Osteoarthritis (OA) is a multifactorial disease that affects the entire joint, often resulting in
severe pain, disability, psychological distress, and a lower quality of life. Patient self …

Nanomedicine for intra-articular drug delivery in rheumatoid arthritis

H OMary, Z Cui - Current Medicinal Chemistry, 2016 - ingentaconnect.com
Rheumatoid arthritis is characterized by chronic inflammation within the joint. Recent
developments in the understanding of inflammation have led to an increased interest in the …

Nanoparticles for the management of osteoarthritis: An Overview

P Prabhu - Journal of Drug Delivery Science and Technology, 2024 - Elsevier
Osteoarthritis is an incapacitating disease involving chronic pain and inflammation of joints
culminating in a compromised quality of life [1]. The World Health Organization (WHO) has …